30 Jan 2015 --- Science may be one step closer to treating diabetes with a human probiotic pill, according to new Cornell University research. In the study, published Jan. 27 in the journal Diabetes, the researchers engineered a strain of lactobacillus, a human probiotic common in the gut, to secrete a Glucagon-like peptide 1 (GLP-1).
